ISAVUCONAZONIUM SULFATE

ISAVUCONAZONIUM SULFATE was reported 3844 times

ISAVUCONAZONIUM SULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TRACHEOSCOPY ABNORMAL 2 0.6667
1 DYSKALAEMIA 3 0.5000
2 RETICULOCYTE HAEMOGLOBIN DECREASED 2 0.2857
3 MENINGITIS ASPERGILLUS 3 0.2143
4 PARAINFLUENZA VIRUS TEST POSITIVE 2 0.1538
5 IDH DIFFERENTIATION SYNDROME 2 0.0909
6 RUBULAVIRUS TEST POSITIVE 2 0.0769
7 MYOCLONIC DYSTONIA 3 0.0612
8 LIP SQUAMOUS CELL CARCINOMA 10 0.0595
9 ACUTE MYELOID LEUKAEMIA (IN REMISSION) 2 0.0588
10 ENDOCARDITIS CANDIDA 3 0.0395
11 CORYNEBACTERIUM SEPSIS 2 0.0303
12 DEFICIENCY OF BILE SECRETION 3 0.0300
13 COMBINED PULMONARY FIBROSIS AND EMPHYSEMA 2 0.0282
14 ACQUIRED CORNEAL DYSTROPHY 1 0.0263
15 MYELOBLAST COUNT INCREASED 2 0.0260
16 CAR T-CELL-RELATED ENCEPHALOPATHY SYNDROME 3 0.0242
17 HERPES SIMPLEX VIRAEMIA 3 0.0240
18 ALBUMIN GLOBULIN RATIO ABNORMAL 1 0.0233
19 ADENOVIRUS TEST POSITIVE 2 0.0211
20 ACINETOBACTER TEST POSITIVE 4 0.0206
21 FUSARIUM INFECTION 13 0.0186
22 CSF VOLUME INCREASED 2 0.0168
23 CUTANEOUS MUCORMYCOSIS 3 0.0163
24 PULMONARY MUCORMYCOSIS 7 0.0133
25 ENTEROBACTER BACTERAEMIA 4 0.0132
26 COMPLICATIONS OF TRANSPLANTED LUNG 4 0.0130
27 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 4 0.0129
28 LOWER RESPIRATORY TRACT INFECTION FUNGAL 5 0.0129
29 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING 3 0.0127
30 ASPERGILLOMA 4 0.0125
31 ADMINISTRATION SITE WARMTH 1 0.0122
32 ARTERY DISSECTION 5 0.0121
33 EPIDERMODYSPLASIA VERRUCIFORMIS 2 0.0119
34 HUMAN HERPESVIRUS 8 INFECTION 7 0.0115
35 INTRACARDIAC MASS 2 0.0113
36 PSYCHOTIC DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0111
37 ASPERGILLUS INFECTION 72 0.0110
38 MUCORMYCOSIS 28 0.0108
39 LARYNGEAL INFLAMMATION 2 0.0106
40 CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE 2 0.0105
41 BURKHOLDERIA CEPACIA COMPLEX INFECTION 3 0.0105
42 PNEUMONIA FUNGAL 41 0.0104
43 SEPTIC PULMONARY EMBOLISM 2 0.0103
44 ECTHYMA 4 0.0100
45 HYPOCHROMASIA 2 0.0100
46 CEREBRAL ASPERGILLOSIS 6 0.0098
47 ASPERGILLUS TEST POSITIVE 3 0.0097
48 CLOSTRIDIUM BACTERAEMIA 2 0.0093
49 SINUSITIS FUNGAL 7 0.0087
50 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 2 0.0086
51 SCEDOSPORIUM INFECTION 6 0.0085
52 SEVERE CUTANEOUS ADVERSE REACTION 2 0.0084
53 ENTEROBACTER TEST POSITIVE 2 0.0081
54 MICROCYTOSIS 2 0.0081
55 ACUTE MYELOMONOCYTIC LEUKAEMIA 2 0.0079
56 LUNG TRANSPLANT REJECTION 5 0.0076
57 CATHETER SITE THROMBOSIS 2 0.0073
58 ENCEPHALOMALACIA 4 0.0071
59 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 6 0.0067
60 KLEBSIELLA TEST POSITIVE 4 0.0061
61 SEPSIS SYNDROME 3 0.0060
62 PNEUMONIA ESCHERICHIA 2 0.0059
63 ACUTE MYELOID LEUKAEMIA REFRACTORY 1 0.0058
64 ANION GAP DECREASED 2 0.0057
65 BLAST CELL COUNT INCREASED 6 0.0057
66 ABSCESS FUNGAL 1 0.0057
67 GRAFT VERSUS HOST DISEASE IN LIVER 4 0.0056
68 CELL DEATH 11 0.0055
69 COMPLICATIONS OF BONE MARROW TRANSPLANT 2 0.0055
70 STREPTOCOCCAL BACTERAEMIA 6 0.0055
71 ALTERNARIA INFECTION 2 0.0054
72 LEUKAEMIA RECURRENT 9 0.0053
73 SUSPECTED OFF LABEL USE 24 0.0053
74 PNEUMONIA PSEUDOMONAL 8 0.0052
75 ACUTE MYELOID LEUKAEMIA RECURRENT 11 0.0051
76 DISSEMINATED MUCORMYCOSIS 2 0.0051
77 BRONCHOPULMONARY ASPERGILLOSIS 39 0.0050
78 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 13 0.0049
79 ADENOVIRAL HAEMORRHAGIC CYSTITIS 1 0.0048
80 SYSTEMIC CANDIDA 12 0.0048
81 TRANSPLANTATION COMPLICATION 2 0.0048
82 ADULT FAILURE TO THRIVE 1 0.0047
83 TRANSFERRIN SATURATION DECREASED 2 0.0047
84 PSEUDOMONAL BACTERAEMIA 4 0.0047
85 ACUTE ON CHRONIC LIVER FAILURE 1 0.0046
86 ACUTE MOTOR-SENSORY AXONAL NEUROPATHY 1 0.0043
87 NEUROENDOCRINE CARCINOMA 3 0.0043
88 SYSTEMIC MYCOSIS 5 0.0043
89 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 3 0.0043
90 AMOEBIASIS 1 0.0043
91 BONE MARROW TRANSPLANT 8 0.0042
92 MYCOBACTERIUM ABSCESSUS INFECTION 3 0.0042
93 PNEUMOCYSTIS JIROVECII INFECTION 5 0.0042
94 ARTERIOVENOUS FISTULA 2 0.0041
95 ORBITAL OEDEMA 2 0.0040
96 METAPNEUMOVIRUS INFECTION 3 0.0038
97 GROWTH OF EYELASHES 3 0.0038
98 RESPIRATORY TRACT INFECTION FUNGAL 2 0.0038
99 DRUG LEVEL ABNORMAL 2 0.0038
100 CHRONIC MYELOID LEUKAEMIA RECURRENT 2 0.0037
101 MIXED LIVER INJURY 11 0.0037
102 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 9 0.0035
103 SPLENIC INFARCTION 6 0.0034
104 PROCALCITONIN INCREASED 4 0.0034
105 LUNG TRANSPLANT 12 0.0034
106 HYPERLEUKOCYTOSIS 3 0.0034
107 GRAFT VERSUS HOST DISEASE 24 0.0033
108 ACUTE MYELOID LEUKAEMIA 52 0.0033
109 PARAINFLUENZAE VIRUS INFECTION 5 0.0033
110 PNEUMONIA KLEBSIELLA 6 0.0033
111 BLOOD BILIRUBIN DECREASED 2 0.0032
112 POST-ACUTE COVID-19 SYNDROME 4 0.0032
113 BLOOD IRON INCREASED 6 0.0032
114 PULPITIS DENTAL 3 0.0032
115 KLEBSIELLA BACTERAEMIA 3 0.0032
116 INCREASED VISCOSITY OF BRONCHIAL SECRETION 2 0.0031
117 PLATELET TRANSFUSION 4 0.0031
118 MYCOBACTERIUM AVIUM COMPLEX INFECTION 8 0.0030
119 CARBON DIOXIDE INCREASED 4 0.0029
120 HEART TRANSPLANT REJECTION 3 0.0029
121 ENTEROCOCCAL BACTERAEMIA 3 0.0028
122 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 17 0.0028
123 BLOOD FOLATE DECREASED 2 0.0028
124 ARRHYTHMIA SUPRAVENTRICULAR 3 0.0027
125 DIFFERENTIATION SYNDROME 2 0.0027
126 OSMOTIC DEMYELINATION SYNDROME 2 0.0027
127 CREATININE RENAL CLEARANCE INCREASED 2 0.0027
128 CHOLANGITIS ACUTE 2 0.0026
129 BASOPHIL COUNT INCREASED 2 0.0026
130 FUNGAEMIA 4 0.0025
131 DRUG LEVEL BELOW THERAPEUTIC 14 0.0025
132 PLACENTAL INSUFFICIENCY 2 0.0025
133 CHRONIC RESPIRATORY FAILURE 3 0.0025
134 ENTEROCOCCAL SEPSIS 2 0.0025
135 DYSBIOSIS 2 0.0024
136 GLOMERULAR FILTRATION RATE INCREASED 2 0.0024
137 DYSCHROMATOPSIA 2 0.0024
138 RENAL ATROPHY 3 0.0024
139 STARVATION 2 0.0024
140 SUPERFICIAL VEIN THROMBOSIS 2 0.0024
141 ALVEOLAR OSTEITIS 1 0.0024
142 HYPERPHOSPHATAEMIA 5 0.0023
143 TRANSFUSION REACTION 2 0.0023
144 FEBRILE NEUTROPENIA 151 0.0023
145 FOLLICULAR LYMPHOMA 2 0.0023
146 CANDIDA SEPSIS 2 0.0022
147 STENOTROPHOMONAS INFECTION 3 0.0022
148 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0022
149 OPPORTUNISTIC INFECTION 4 0.0022
150 ECHOCARDIOGRAM ABNORMAL 3 0.0021
151 VENOUS INJURY 2 0.0021
152 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 3 0.0021
153 LEUKAEMIA 20 0.0021
154 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 2 0.0021
155 DELAYED RECOVERY FROM ANAESTHESIA 2 0.0021
156 TRANSPLANT 5 0.0021
157 POTENTIATING DRUG INTERACTION 7 0.0021
158 RHINOVIRUS INFECTION 8 0.0021
159 GENERALISED ANXIETY DISORDER 3 0.0020
160 GASTROINTESTINAL WALL THICKENING 3 0.0020
161 VASCULAR DEVICE INFECTION 9 0.0020
162 EAR HAEMORRHAGE 4 0.0020
163 STEROID WITHDRAWAL SYNDROME 2 0.0020
164 GASTROSTOMY 3 0.0019
165 LUNG OPACITY 5 0.0019
166 OPTIC NEUROPATHY 4 0.0019
167 ENTEROCOCCAL INFECTION 9 0.0019
168 KIDNEY ENLARGEMENT 2 0.0018
169 ACINETOBACTER INFECTION 2 0.0018
170 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 6 0.0018
171 CYSTIC FIBROSIS 10 0.0018
172 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 3 0.0018
173 ACUTE LYMPHOCYTIC LEUKAEMIA 5 0.0018
174 FUNGAL INFECTION 58 0.0017
175 CEREBRAL VENTRICLE DILATATION 2 0.0017
176 PAROTITIS 2 0.0017
177 APLASTIC ANAEMIA 9 0.0017
178 TUMOUR LYSIS SYNDROME 15 0.0017
179 AMBLYOPIA 1 0.0017
180 ACUTE LUNG INJURY 2 0.0017
181 NEPHROCALCINOSIS 2 0.0017
182 COCCIDIOIDOMYCOSIS 2 0.0017
183 ESCHERICHIA TEST POSITIVE 2 0.0017
184 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 2 0.0017
185 DYSPLASIA 2 0.0017
186 GASTROINTESTINAL TOXICITY 8 0.0017
187 SQUAMOUS CELL CARCINOMA OF SKIN 10 0.0017
188 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 9 0.0017
189 PATHOGEN RESISTANCE 15 0.0016
190 MONOCYTE COUNT DECREASED 2 0.0016
191 MEAN CELL HAEMOGLOBIN DECREASED 3 0.0016
192 DISORGANISED SPEECH 3 0.0016
193 STAPHYLOCOCCAL BACTERAEMIA 7 0.0016
194 STEM CELL TRANSPLANT 4 0.0016
195 NEUTROPHIL PERCENTAGE INCREASED 2 0.0016
196 BRONCHIAL SECRETION RETENTION 2 0.0016
197 HEPATIC CYTOLYSIS 20 0.0016
198 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
199 PHYSICAL DECONDITIONING 4 0.0016
200 SLOW RESPONSE TO STIMULI 2 0.0015
201 PSYCHIATRIC DECOMPENSATION 3 0.0015
202 GAMMA-GLUTAMYLTRANSFERASE INCREASED 34 0.0015
203 RESPIRATORY ACIDOSIS 6 0.0015
204 OBLITERATIVE BRONCHIOLITIS 2 0.0015
205 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 9 0.0015
206 INTESTINAL DILATATION 2 0.0015
207 CAPILLARY LEAK SYNDROME 3 0.0014
208 NEUTROPENIC COLITIS 3 0.0014
209 BLOOD ALKALINE PHOSPHATASE INCREASED 36 0.0014
210 PERIODONTAL DISEASE 2 0.0014
211 NEUTROPHIL COUNT ABNORMAL 4 0.0014
212 UTERINE RUPTURE 2 0.0014
213 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 3 0.0014
214 PERIODONTITIS 3 0.0014
215 CHRONIC GRAFT VERSUS HOST DISEASE 5 0.0014
216 GRAFT VERSUS HOST DISEASE IN SKIN 3 0.0014
217 BACTERAEMIA 16 0.0013
218 BONE MARROW DISORDER 4 0.0013
219 DRUG RESISTANCE 34 0.0013
220 PLATELET COUNT ABNORMAL 8 0.0013
221 DRUG LEVEL ABOVE THERAPEUTIC 6 0.0013
222 PNEUMONIA BACTERIAL 12 0.0013
223 CYTOPENIA 16 0.0013
224 MULTIPLE ORGAN DYSFUNCTION SYNDROME 37 0.0013
225 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 3 0.0013
226 MEAN CELL VOLUME DECREASED 2 0.0013
227 DRUG LEVEL DECREASED 13 0.0013
228 ESCHERICHIA BACTERAEMIA 3 0.0013
229 PUSTULE 3 0.0013
230 PHARYNGEAL PARAESTHESIA 2 0.0013
231 EOSINOPHIL COUNT DECREASED 3 0.0013
232 WHITE BLOOD CELL COUNT ABNORMAL 8 0.0013
233 OPTIC NERVE DISORDER 2 0.0012
234 OFF LABEL USE 1094 0.0012
235 ACUTE RESPIRATORY FAILURE 24 0.0012
236 NEPHROPATHY TOXIC 14 0.0012
237 CYTOKINE RELEASE SYNDROME 25 0.0012
238 HAEMOGLOBIN ABNORMAL 8 0.0012
239 FUNGAL SKIN INFECTION 5 0.0012
240 SUFFOCATION FEELING 3 0.0012
241 PERIPHERAL SENSORY NEUROPATHY 7 0.0012
242 PLATELET DISORDER 3 0.0012
243 MALIGNANT PLEURAL EFFUSION 2 0.0012
244 BRAIN ABSCESS 3 0.0012
245 AGRANULOCYTOSIS 22 0.0012
246 TACHYPNOEA 16 0.0012
247 PETIT MAL EPILEPSY 6 0.0012
248 HEPATOSPLENOMEGALY 3 0.0012
249 BLOOD CHLORIDE DECREASED 3 0.0012
250 HYPERTRANSAMINASAEMIA 8 0.0011
251 OTORRHOEA 2 0.0011
252 PSEUDOMONAL SEPSIS 2 0.0011
253 HISTOPLASMOSIS 2 0.0011
254 MITRAL VALVE DISEASE 2 0.0011
255 CYTOMEGALOVIRUS VIRAEMIA 5 0.0011
256 STEATORRHOEA 3 0.0011
257 HOSPICE CARE 11 0.0011
258 NASAL OEDEMA 2 0.0011
259 ANAEMIA OF CHRONIC DISEASE 1 0.0011
260 DRUG LEVEL INCREASED 18 0.0011
261 LYMPH NODE PAIN 2 0.0011
262 MUCOSAL INFLAMMATION 28 0.0011
263 HYPOGAMMAGLOBULINAEMIA 7 0.0011
264 CORONAVIRUS INFECTION 7 0.0011
265 HYPOPROTEINAEMIA 2 0.0011
266 CHRONIC LYMPHOCYTIC LEUKAEMIA 5 0.0011
267 BRONCHOSPASM 15 0.0011
268 HAEMOPTYSIS 29 0.0010
269 LUNG INFILTRATION 9 0.0010
270 HYPERAEMIA 2 0.0010
271 PNEUMONIA STAPHYLOCOCCAL 2 0.0010
272 VENOOCCLUSIVE LIVER DISEASE 5 0.0010
273 ATYPICAL PNEUMONIA 3 0.0010
274 HEPATIC ENZYME ABNORMAL 5 0.0010
275 BLOOD BILIRUBIN INCREASED 27 0.0010
276 HEPATITIS CHOLESTATIC 6 0.0010
277 DYSPHORIA 5 0.0010
278 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 5 0.0010
279 RECURRENT CANCER 4 0.0010
280 LIVER FUNCTION TEST INCREASED 21 0.0010
281 NEUROTOXICITY 17 0.0010
282 IMPAIRED SELF-CARE 2 0.0010
283 BLOOD CREATININE DECREASED 3 0.0010
284 TRANSFUSION 10 0.0010
285 BLOOD LACTIC ACID INCREASED 5 0.0009
286 CANDIDA INFECTION 16 0.0009
287 CATHETER SITE ERYTHEMA 2 0.0009
288 SEPTIC SHOCK 40 0.0009
289 HENOCH-SCHONLEIN PURPURA 2 0.0009
290 CEREBELLAR SYNDROME 2 0.0009
291 NOSOCOMIAL INFECTION 2 0.0009
292 HEPATOTOXICITY 20 0.0009
293 CHOLECYSTITIS ACUTE 5 0.0009
294 URINE ABNORMALITY 4 0.0009
295 DISEASE PROGRESSION 104 0.0009
296 ACUTE GRAFT VERSUS HOST DISEASE 4 0.0009
297 DISEASE COMPLICATION 4 0.0009
298 CENTRAL NERVOUS SYSTEM LESION 12 0.0009
299 GRANULOMA 3 0.0009
300 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 2 0.0009
301 RESPIRATORY TRACT INFECTION VIRAL 2 0.0009
302 SINUS PAIN 2 0.0009
303 TRANSAMINASES INCREASED 19 0.0009
304 BRONCHIOLITIS 3 0.0009
305 HYPOXIA 30 0.0009
306 FULL BLOOD COUNT ABNORMAL 9 0.0009
307 FIBRIN D DIMER INCREASED 3 0.0008
308 RED BLOOD CELL COUNT DECREASED 24 0.0008
309 MYELODYSPLASTIC SYNDROME 12 0.0008
310 DRUG-INDUCED LIVER INJURY 26 0.0008
311 BREATH ODOUR 2 0.0008
312 TRANSPLANT FAILURE 2 0.0008
313 AMYLASE INCREASED 3 0.0008
314 STAPHYLOCOCCAL SEPSIS 4 0.0008
315 BLOOD IMMUNOGLOBULIN G DECREASED 2 0.0008
316 CATHETER SITE HAEMORRHAGE 2 0.0008
317 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 6 0.0008
318 IMMUNOSUPPRESSION 7 0.0008
319 URINARY TRACT INFECTION BACTERIAL 2 0.0008
320 NEUTROPHIL COUNT INCREASED 8 0.0008
321 ADENOCARCINOMA PANCREAS 1 0.0008
322 FAILURE TO THRIVE 4 0.0008
323 BLOOD POTASSIUM ABNORMAL 2 0.0007
324 CREATININE RENAL CLEARANCE DECREASED 3 0.0007
325 BLOOD POTASSIUM INCREASED 12 0.0007
326 SPUTUM DISCOLOURED 7 0.0007
327 IMMUNODEFICIENCY 11 0.0007
328 GASTRIC PERFORATION 2 0.0007
329 ENCEPHALOPATHY 18 0.0007
330 BLOOD PHOSPHORUS INCREASED 2 0.0007
331 ABSCESS ORAL 1 0.0007
332 RHINALGIA 2 0.0007
333 HEPATIC FUNCTION ABNORMAL 27 0.0007
334 OBSTRUCTIVE AIRWAYS DISORDER 8 0.0007
335 LUNG CONSOLIDATION 2 0.0007
336 ENDOTRACHEAL INTUBATION 2 0.0007
337 ACUTE PULMONARY OEDEMA 4 0.0007
338 RENAL TUBULAR DISORDER 2 0.0007
339 ALVEOLITIS 1 0.0007
340 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 1 0.0007
341 PLATELET COUNT DECREASED 75 0.0007
342 RETINAL HAEMORRHAGE 5 0.0007
343 BACTERIAL INFECTION 13 0.0007
344 PNEUMOTHORAX 11 0.0007
345 FAECES SOFT 5 0.0007
346 INCORRECT PRODUCT STORAGE 9 0.0007
347 GINGIVAL SWELLING 3 0.0007
348 ACUTE RESPIRATORY DISTRESS SYNDROME 12 0.0007
349 OSTEOMYELITIS 12 0.0007
350 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
351 RESPIRATORY FAILURE 48 0.0007
352 HYPERTHERMIA 5 0.0007
353 FIBROSIS 2 0.0006
354 SMALL INTESTINAL OBSTRUCTION 8 0.0006
355 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
356 RENAL FUNCTION TEST ABNORMAL 3 0.0006
357 DRUG INTERACTION 102 0.0006
358 APNOEA 5 0.0006
359 SINUS TACHYCARDIA 9 0.0006
360 ELECTROENCEPHALOGRAM ABNORMAL 2 0.0006
361 NON-CARDIAC CHEST PAIN 2 0.0006
362 HYPERKALAEMIA 22 0.0006
363 MALNUTRITION 7 0.0006
364 CHOLESTASIS 12 0.0006
365 TRANSPLANT REJECTION 5 0.0006
366 CUSHINGOID 2 0.0006
367 ACUTE LEUKAEMIA 1 0.0006
368 SEPSIS 69 0.0006
369 LIVER ABSCESS 2 0.0006
370 BACTERIAL SEPSIS 2 0.0006
371 ESCHERICHIA INFECTION 5 0.0006
372 HYPERVOLAEMIA 3 0.0006
373 MUCOUS STOOLS 3 0.0006
374 DELIRIUM 21 0.0006
375 HYPERNATRAEMIA 3 0.0006
376 SECOND PRIMARY MALIGNANCY 5 0.0006
377 CARDIAC FAILURE ACUTE 4 0.0006
378 KLEBSIELLA INFECTION 3 0.0006
379 BK VIRUS INFECTION 2 0.0006
380 TASTE DISORDER 12 0.0006
381 ATAXIA 7 0.0006
382 ELECTROCARDIOGRAM QT PROLONGED 21 0.0006
383 ACUTE SINUSITIS 1 0.0006
384 ACUTE KIDNEY INJURY 88 0.0006
385 RESPIRATORY SYNCYTIAL VIRUS INFECTION 5 0.0006
386 THROMBOPHLEBITIS 2 0.0006
387 LIVER INJURY 14 0.0006
388 SERUM FERRITIN INCREASED 3 0.0006
389 HALLUCINATION, VISUAL 12 0.0006
390 SKIN WEEPING 2 0.0006
391 INTERCEPTED PRODUCT STORAGE ERROR 2 0.0006
392 FOOD POISONING 3 0.0006
393 PRODUCT SIZE ISSUE 3 0.0006
394 MONOCYTE COUNT INCREASED 2 0.0006
395 FULL BLOOD COUNT DECREASED 11 0.0005
396 ANAPHYLACTIC SHOCK 14 0.0005
397 LIVER DISORDER 24 0.0005
398 STREPTOCOCCAL INFECTION 3 0.0005
399 NECROSIS 3 0.0005
400 NEUTROPENIA 73 0.0005
401 PULMONARY ALVEOLAR HAEMORRHAGE 3 0.0005
402 PANCREATITIS ACUTE 12 0.0005
403 PRODUCT STORAGE ISSUE 2 0.0005
404 DIFFUSE LARGE B-CELL LYMPHOMA 4 0.0005
405 REHABILITATION THERAPY 2 0.0005
406 ELECTROLYTE IMBALANCE 6 0.0005
407 LUNG INFECTION 8 0.0005
408 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
409 PULMONARY HAEMORRHAGE 4 0.0005
410 GASTROINTESTINAL INFLAMMATION 4 0.0005
411 HAEMATOCRIT DECREASED 10 0.0005
412 BLOOD ALBUMIN DECREASED 4 0.0005
413 HYPOMAGNESAEMIA 7 0.0005
414 ODYNOPHAGIA 3 0.0005
415 CEREBRAL ATROPHY 2 0.0005
416 PROTHROMBIN TIME PROLONGED 3 0.0005
417 RENAL IMPAIRMENT 42 0.0005
418 HEPATIC FAILURE 15 0.0005
419 INFECTION 71 0.0005
420 ABNORMAL FAECES 4 0.0005
421 HICCUPS 4 0.0005
422 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
423 ANAPHYLACTOID REACTION 2 0.0005
424 DYSPHAGIA 46 0.0005
425 SOCIAL PROBLEM 2 0.0005
426 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
427 CYTOMEGALOVIRUS INFECTION 8 0.0005
428 GASTROINTESTINAL PERFORATION 2 0.0005
429 EPSTEIN-BARR VIRUS INFECTION 3 0.0005
430 BLOOD SODIUM DECREASED 9 0.0005
431 PRODUCT ODOUR ABNORMAL 5 0.0005
432 HAEMOGLOBIN DECREASED 49 0.0005
433 HALLUCINATIONS, MIXED 2 0.0005
434 FACE OEDEMA 8 0.0005
435 THROAT CANCER 2 0.0005
436 SCREAMING 3 0.0005
437 WHITE BLOOD CELL COUNT DECREASED 51 0.0005
438 ENTERITIS 3 0.0005
439 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
440 UNDERDOSE 34 0.0005
441 METASTATIC NEOPLASM 2 0.0005
442 POOR QUALITY DRUG ADMINISTERED 3 0.0005
443 OXYGEN SATURATION DECREASED 26 0.0005
444 TREATMENT FAILURE 38 0.0005
445 JOINT STIFFNESS 12 0.0005
446 PULMONARY FUNCTION TEST DECREASED 2 0.0005
447 ASPIRATION 5 0.0005
448 EOSINOPHILIA 8 0.0005
449 PURPURA 4 0.0005
450 MENINGITIS 3 0.0004
451 NERVOUS SYSTEM DISORDER 14 0.0004
452 CONDITION AGGRAVATED 136 0.0004
453 ADENOCARCINOMA 1 0.0004
454 MYOSITIS 4 0.0004
455 BRONCHIECTASIS 3 0.0004
456 NEUTROPHIL COUNT DECREASED 18 0.0004
457 LIP DRY 4 0.0004
458 MYOCARDIAL ISCHAEMIA 5 0.0004
459 HYPERGLYCAEMIA 16 0.0004
460 PNEUMONIA 142 0.0004
461 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 31 0.0004
462 PYREXIA 150 0.0004
463 CHRONIC MYELOID LEUKAEMIA 2 0.0004
464 PERICARDIAL EFFUSION 10 0.0004
465 INTERCEPTED MEDICATION ERROR 2 0.0004
466 PANCYTOPENIA 24 0.0004
467 PRODUCT USE IN UNAPPROVED INDICATION 106 0.0004
468 SKIN TIGHTNESS 2 0.0004
469 COVID-19 PNEUMONIA 5 0.0004
470 PRODUCT PACKAGING ISSUE 4 0.0004
471 VIRAL UPPER RESPIRATORY TRACT INFECTION 2 0.0004
472 PULSE ABSENT 2 0.0004
473 COAGULOPATHY 7 0.0004
474 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 23 0.0004
475 HYPOVOLAEMIC SHOCK 2 0.0004
476 DRUG PRESCRIBING ERROR 8 0.0004
477 ASPARTATE AMINOTRANSFERASE INCREASED 22 0.0004
478 BLOOD CREATININE INCREASED 27 0.0004
479 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
480 MAJOR DEPRESSION 3 0.0004
481 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
482 RENAL TUBULAR NECROSIS 4 0.0004
483 ALANINE AMINOTRANSFERASE INCREASED 25 0.0004
484 HEPARIN-INDUCED THROMBOCYTOPENIA 2 0.0004
485 ORGANISING PNEUMONIA 2 0.0004
486 PULMONARY MASS 6 0.0004
487 DEATH 344 0.0004
488 SECRETION DISCHARGE 5 0.0004
489 PNEUMOCYSTIS JIROVECII PNEUMONIA 4 0.0004
490 FEEDING DISORDER 8 0.0004
491 PLEURAL EFFUSION 24 0.0004
492 THROMBOCYTOPENIA 44 0.0004
493 HYPOKALAEMIA 18 0.0004
494 DEVICE RELATED INFECTION 6 0.0004
495 LUNG DISORDER 19 0.0004
496 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 3 0.0004
497 FOETAL DEATH 2 0.0004
498 PERIORBITAL OEDEMA 2 0.0004
499 TREATMENT NONCOMPLIANCE 21 0.0004
500 PLATELET COUNT INCREASED 5 0.0004
501 PETECHIAE 4 0.0004
502 PARTIAL SEIZURES 2 0.0004
503 PRODUCT USE COMPLAINT 6 0.0004
504 LIVER FUNCTION TEST ABNORMAL 11 0.0004
505 ALCOHOL POISONING 1 0.0004
506 ABDOMINAL MASS 1 0.0004
507 ANAL FISSURE 2 0.0004
508 RHINITIS 3 0.0004
509 MUSCLE DISORDER 3 0.0004
510 ALTERED STATE OF CONSCIOUSNESS 8 0.0004
511 CEREBRAL INFARCTION 9 0.0004
512 RESPIRATORY DISORDER 11 0.0004
513 PULMONARY THROMBOSIS 4 0.0004
514 MENTAL STATUS CHANGES 10 0.0004
515 RASH MACULO-PAPULAR 8 0.0004
516 BLOOD UREA INCREASED 6 0.0004
517 CELLULITIS 18 0.0004
518 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
519 HEPATOCELLULAR INJURY 5 0.0004
520 FACIAL PARALYSIS 3 0.0004
521 PSEUDOMONAS INFECTION 3 0.0003
522 SKIN HYPERPIGMENTATION 3 0.0003
523 EPISTAXIS 26 0.0003
524 HERPES VIRUS INFECTION 2 0.0003
525 HYPERTRIGLYCERIDAEMIA 2 0.0003
526 HOSPITALISATION 52 0.0003
527 CHOLECYSTITIS 4 0.0003
528 LOCALISED INFECTION 8 0.0003
529 ADRENAL INSUFFICIENCY 4 0.0003
530 INSURANCE ISSUE 5 0.0003
531 PRODUCT DISPENSING ERROR 7 0.0003
532 MELAENA 7 0.0003
533 TACHYCARDIA 28 0.0003
534 ULCER 5 0.0003
535 CHROMATURIA 7 0.0003
536 DECREASED APPETITE 72 0.0003
537 HERPES SIMPLEX 2 0.0003
538 HEPATITIS ACUTE 2 0.0003
539 PHARYNGEAL SWELLING 3 0.0003
540 BRADYPHRENIA 2 0.0003
541 PRODUCT PREPARATION ISSUE 2 0.0003
542 IMMUNE SYSTEM DISORDER 4 0.0003
543 VENTRICULAR TACHYCARDIA 5 0.0003
544 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
545 INABILITY TO AFFORD MEDICATION 3 0.0003
546 VIRAL INFECTION 10 0.0003
547 LEUKOPENIA 15 0.0003
548 TOXIC SKIN ERUPTION 3 0.0003
549 COLITIS ISCHAEMIC 2 0.0003
550 PRODUCT LABEL ISSUE 2 0.0003
551 HEPATIC ENZYME INCREASED 20 0.0003
552 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
553 INTERSTITIAL LUNG DISEASE 14 0.0003
554 ENCEPHALITIS 2 0.0003
555 ORAL DISCOMFORT 4 0.0003
556 AUTOIMMUNE HEPATITIS 2 0.0003
557 WEIGHT FLUCTUATION 3 0.0003
558 PAPULE 2 0.0003
559 EATING DISORDER 6 0.0003
560 INTENTIONAL DOSE OMISSION 8 0.0003
561 PRODUCT SUPPLY ISSUE 2 0.0003
562 GALLBLADDER DISORDER 5 0.0003
563 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
564 RENAL DISORDER 13 0.0003
565 MYELOSUPPRESSION 10 0.0003
566 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
567 FLUID OVERLOAD 4 0.0003
568 OESOPHAGITIS 3 0.0003
569 CARDIAC FAILURE 22 0.0003
570 PRODUCTIVE COUGH 13 0.0003
571 ANGIOEDEMA 12 0.0003
572 DENTAL CARIES 3 0.0003
573 BLINDNESS TRANSIENT 2 0.0003
574 LABORATORY TEST ABNORMAL 8 0.0003
575 HYPOPHOSPHATAEMIA 2 0.0003
576 URINARY INCONTINENCE 8 0.0003
577 COVID-19 47 0.0003
578 DEAFNESS 7 0.0003
579 HYPONATRAEMIA 15 0.0003
580 PHOTOPHOBIA 5 0.0003
581 HYPOAESTHESIA ORAL 4 0.0003
582 PAROSMIA 2 0.0003
583 HYPOCALCAEMIA 5 0.0003
584 BLOOD COUNT ABNORMAL 4 0.0003
585 PRODUCT AVAILABILITY ISSUE 6 0.0003
586 MYOCARDITIS 3 0.0003
587 ACIDOSIS 2 0.0003
588 POST PROCEDURAL COMPLICATION 5 0.0003
589 ATRIOVENTRICULAR BLOCK 2 0.0003
590 EJECTION FRACTION DECREASED 4 0.0003
591 HYPOALBUMINAEMIA 2 0.0003
592 SPLENOMEGALY 3 0.0003
593 TORSADE DE POINTES 2 0.0003
594 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
595 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
596 BLOOD IRON DECREASED 3 0.0003
597 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
598 THERAPY INTERRUPTED 18 0.0003
599 CEREBRAL HAEMORRHAGE 9 0.0003
600 GINGIVAL PAIN 2 0.0003
601 ATRIAL FLUTTER 2 0.0003
602 MYASTHENIA GRAVIS 2 0.0002
603 C-REACTIVE PROTEIN INCREASED 9 0.0002
604 BONE MARROW FAILURE 5 0.0002
605 DECUBITUS ULCER 2 0.0002
606 BODY TEMPERATURE INCREASED 5 0.0002
607 CHEST PAIN 45 0.0002
608 PNEUMONIA ASPIRATION 6 0.0002
609 NAUSEA 190 0.0002
610 EOSINOPHIL COUNT INCREASED 2 0.0002
611 PRODUCT STORAGE ERROR 21 0.0002
612 BRAIN OEDEMA 3 0.0002
613 ACUTE MYOCARDIAL INFARCTION 7 0.0002
614 MOUTH ULCERATION 5 0.0002
615 MUSCLE ATROPHY 3 0.0002
616 CIRCULATORY COLLAPSE 4 0.0002
617 ABSCESS LIMB 1 0.0002
618 HAEMATURIA 8 0.0002
619 BLOOD POTASSIUM DECREASED 7 0.0002
620 DIPLOPIA 6 0.0002
621 STOMATITIS 14 0.0002
622 FAECES DISCOLOURED 5 0.0002
623 LYMPHOCYTE COUNT DECREASED 4 0.0002
624 RESPIRATORY RATE INCREASED 2 0.0002
625 CHEST DISCOMFORT 23 0.0002
626 ISCHAEMIC STROKE 4 0.0002
627 FACIAL PAIN 2 0.0002
628 PULMONARY OEDEMA 10 0.0002
629 THERAPY NON-RESPONDER 10 0.0002
630 ANAL INCONTINENCE 2 0.0002
631 PRODUCT TASTE ABNORMAL 3 0.0002
632 GASTROENTERITIS VIRAL 4 0.0002
633 HEART RATE IRREGULAR 5 0.0002
634 PNEUMONITIS 6 0.0002
635 NERVE COMPRESSION 2 0.0002
636 PRODUCT DISTRIBUTION ISSUE 2 0.0002
637 VOMITING 101 0.0002
638 HEPATIC STEATOSIS 4 0.0002
639 NEPHROPATHY 2 0.0002
640 APPENDICITIS 2 0.0002
641 BLOOD TEST ABNORMAL 3 0.0002
642 SQUAMOUS CELL CARCINOMA 2 0.0002
643 LYMPHOPENIA 3 0.0002
644 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
645 COLITIS 8 0.0002
646 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
647 COUGH 59 0.0002
648 PRODUCT PRESCRIBING ERROR 5 0.0002
649 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2 0.0002
650 CARDIOGENIC SHOCK 3 0.0002
651 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
652 PULMONARY FIBROSIS 4 0.0002
653 EAR PAIN 4 0.0002
654 APATHY 3 0.0002
655 THROMBOTIC MICROANGIOPATHY 2 0.0002
656 HAEMORRHOIDS 4 0.0002
657 ORAL HERPES 4 0.0002
658 HYPOTENSION 41 0.0002
659 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
660 HEPATOMEGALY 2 0.0002
661 THERAPY CHANGE 2 0.0002
662 CARDIOMYOPATHY 3 0.0002
663 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 41 0.0002
664 PRODUCT USE ISSUE 38 0.0002
665 ABDOMINAL TENDERNESS 1 0.0002
666 GASTROINTESTINAL DISORDER 18 0.0002
667 HAEMORRHAGE INTRACRANIAL 3 0.0002
668 AGEUSIA 5 0.0002
669 DEEP VEIN THROMBOSIS 13 0.0002
670 SLEEP DISORDER 14 0.0002
671 PRODUCT PHYSICAL ISSUE 4 0.0002
672 EMPHYSEMA 2 0.0002
673 LYMPHADENOPATHY 7 0.0002
674 TOOTH ABSCESS 2 0.0002
675 INFUSION RELATED REACTION 13 0.0002
676 HYPOPHAGIA 5 0.0002
677 HEPATITIS 5 0.0002
678 ATRIAL FIBRILLATION 19 0.0002
679 EAR DISCOMFORT 2 0.0002
680 NEOPLASM MALIGNANT 13 0.0002
681 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
682 INTENTIONAL PRODUCT USE ISSUE 17 0.0002
683 ANAEMIA 37 0.0002
684 MUSCULOSKELETAL CHEST PAIN 3 0.0002
685 HYPERBILIRUBINAEMIA 2 0.0002
686 VENTRICULAR EXTRASYSTOLES 2 0.0002
687 DYSPNOEA 109 0.0002
688 PULMONARY HYPERTENSION 4 0.0002
689 RHABDOMYOLYSIS 8 0.0002
690 GASTROINTESTINAL HAEMORRHAGE 16 0.0002
691 BRAIN FOG 3 0.0002
692 POOR QUALITY PRODUCT ADMINISTERED 2 0.0002
693 DISEASE RECURRENCE 9 0.0002
694 RESPIRATORY TRACT CONGESTION 3 0.0002
695 BRADYCARDIA 10 0.0002
696 DYSGEUSIA 14 0.0002
697 RETCHING 4 0.0002
698 CONFUSIONAL STATE 30 0.0002
699 WHEEZING 11 0.0002
700 OEDEMA 10 0.0002
701 EYE DISORDER 6 0.0002
702 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
703 SKIN LESION 5 0.0002
704 PHOTOSENSITIVITY REACTION 3 0.0002
705 GENERAL PHYSICAL HEALTH DETERIORATION 21 0.0002
706 TOOTH FRACTURE 2 0.0002
707 RESPIRATORY ARREST 5 0.0002
708 RESPIRATORY DISTRESS 5 0.0002
709 RENAL FAILURE 24 0.0002
710 LOSS OF CONSCIOUSNESS 23 0.0002
711 NEUROPATHY PERIPHERAL 17 0.0002
712 PERICARDITIS 3 0.0002
713 INTESTINAL PERFORATION 2 0.0002
714 OCULAR DISCOMFORT 2 0.0002
715 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
716 HEMIPARESIS 3 0.0002
717 STATUS EPILEPTICUS 2 0.0002
718 REBOUND EFFECT 2 0.0002
719 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
720 DISORIENTATION 7 0.0002
721 DIARRHOEA 114 0.0002
722 ABDOMINAL PAIN 41 0.0002
723 MUSCULAR WEAKNESS 20 0.0002
724 PERIPHERAL SWELLING 27 0.0002
725 MUSCULOSKELETAL DISCOMFORT 3 0.0002
726 SHOCK 4 0.0002
727 ABDOMINAL DISTENSION 18 0.0002
728 VASCULITIS 2 0.0002
729 CARDIAC ARREST 14 0.0002
730 VISUAL IMPAIRMENT 21 0.0002
731 HEAD DISCOMFORT 3 0.0002
732 THIRST 3 0.0002
733 CARDIO-RESPIRATORY ARREST 7 0.0002
734 LEUKOCYTOSIS 3 0.0002
735 DRUG INTOLERANCE 16 0.0002
736 APHASIA 5 0.0002
737 MENTAL IMPAIRMENT 4 0.0002
738 NEURALGIA 4 0.0002
739 OEDEMA PERIPHERAL 20 0.0002
740 SOMNOLENCE 33 0.0002
741 FEELING HOT 10 0.0002
742 FATIGUE 127 0.0002
743 TREMOR 27 0.0002
744 ASTHENIA 61 0.0002
745 CHILLS 19 0.0002
746 HYPERCALCAEMIA 2 0.0002
747 THROMBOSIS 13 0.0002
748 GENERALISED OEDEMA 2 0.0002
749 DYSPNOEA EXERTIONAL 6 0.0002
750 BLOOD URINE PRESENT 3 0.0002
751 CHRONIC KIDNEY DISEASE 12 0.0002
752 PULMONARY EMBOLISM 15 0.0002
753 HAEMATEMESIS 4 0.0002
754 MUSCULOSKELETAL DISORDER 3 0.0002
755 FLUID RETENTION 8 0.0002
756 ILLNESS 16 0.0002
757 ERUCTATION 3 0.0002
758 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
759 WEIGHT DECREASED 43 0.0002
760 CHOKING 3 0.0002
761 NODULE 2 0.0002
762 MUSCULOSKELETAL PAIN 8 0.0002
763 BEDRIDDEN 2 0.0002
764 STAPHYLOCOCCAL INFECTION 5 0.0002
765 SINUS DISORDER 3 0.0002
766 RASH 66 0.0002
767 VISUAL ACUITY REDUCED 5 0.0002
768 BLOOD PRESSURE DECREASED 10 0.0002
769 PRESCRIBED UNDERDOSE 3 0.0002
770 EAR INFECTION 4 0.0002
771 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 27 0.0001
772 SPINAL FRACTURE 3 0.0001
773 PRODUCT DOSE OMISSION ISSUE 44 0.0001
774 HAIR TEXTURE ABNORMAL 2 0.0001
775 QUALITY OF LIFE DECREASED 2 0.0001
776 JAUNDICE 4 0.0001
777 SINUS CONGESTION 2 0.0001
778 ARRHYTHMIA 7 0.0001
779 VERTIGO 9 0.0001
780 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
781 PERIPHERAL COLDNESS 2 0.0001
782 DIVERTICULITIS 4 0.0001
783 INFLUENZA 16 0.0001
784 APHONIA 2 0.0001
785 MASS 2 0.0001
786 BLISTER 8 0.0001
787 DEHYDRATION 19 0.0001
788 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
789 FLATULENCE 8 0.0001
790 ABDOMINAL PAIN UPPER 29 0.0001
791 HYPERSOMNIA 4 0.0001
792 HYPOACUSIS 6 0.0001
793 ACCIDENTAL UNDERDOSE 2 0.0001
794 SWELLING FACE 9 0.0001
795 ANOSMIA 2 0.0001
796 MENTAL DISORDER 6 0.0001
797 PRODUCT DOSE OMISSION 9 0.0001
798 PRODUCT PRESCRIBING ISSUE 3 0.0001
799 GASTROENTERITIS 2 0.0001
800 DYSSTASIA 4 0.0001
801 INFLAMMATION 7 0.0001
802 SKIN HAEMORRHAGE 2 0.0001
803 ORAL PAIN 3 0.0001
804 PANCREATITIS 7 0.0001
805 DRUG INEFFECTIVE 173 0.0001
806 ABDOMINAL DISCOMFORT 22 0.0001
807 TINNITUS 6 0.0001
808 SKIN DISCOLOURATION 6 0.0001
809 MUSCLE TWITCHING 3 0.0001
810 MALAISE 57 0.0001
811 SEIZURE 15 0.0001
812 LYMPHOMA 2 0.0001
813 TENDONITIS 2 0.0001
814 BACK PAIN 30 0.0001
815 URINARY TRACT INFECTION 22 0.0001
816 PLASMA CELL MYELOMA 5 0.0001
817 CYANOSIS 2 0.0001
818 COMA 6 0.0001
819 OBESITY 2 0.0001
820 RASH ERYTHEMATOUS 6 0.0001
821 SCIATICA 2 0.0001
822 EYE PAIN 7 0.0001
823 MUSCLE TIGHTNESS 2 0.0001
824 CHOLELITHIASIS 4 0.0001
825 OSTEONECROSIS 4 0.0001
826 LETHARGY 7 0.0001
827 LIP SWELLING 4 0.0001
828 GAIT INABILITY 4 0.0001
829 HALLUCINATION 9 0.0001
830 HOT FLUSH 9 0.0001
831 CONSTIPATION 26 0.0001
832 UNEVALUABLE EVENT 9 0.0001
833 ABDOMINAL PAIN LOWER 3 0.0001
834 MALIGNANT NEOPLASM PROGRESSION 12 0.0001
835 SINUSITIS 12 0.0001
836 UNRESPONSIVE TO STIMULI 3 0.0001
837 ORTHOSTATIC HYPOTENSION 2 0.0001
838 ARTHRITIS 9 0.0001
839 GASTRITIS 3 0.0001
840 HYPERTENSION 24 0.0001
841 DRUG ERUPTION 2 0.0001
842 DRY SKIN 15 0.0001
843 DYSPEPSIA 11 0.0001
844 GASTROOESOPHAGEAL REFLUX DISEASE 9 0.0001
845 GOUT 2 0.0001
846 THROAT IRRITATION 5 0.0001
847 BLOOD PRESSURE INCREASED 17 0.0001
848 TOOTHACHE 2 0.0001
849 VISION BLURRED 15 0.0001
850 HAEMATOCHEZIA 6 0.0001
851 HEADACHE 68 0.0001
852 DEMENTIA 3 0.0001
853 ALOPECIA 21 0.0001
854 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
855 SKIN EXFOLIATION 9 0.0001
856 INTESTINAL OBSTRUCTION 4 0.0001
857 MYALGIA 18 0.0001
858 ARTHRALGIA 44 0.0001
859 GASTRIC ULCER 2 0.0001
860 INCORRECT DOSE ADMINISTERED 24 0.0001
861 SLEEP APNOEA SYNDROME 2 0.0001
862 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
863 AFFECT LABILITY 1 0.0001
864 PRESCRIBED OVERDOSE 2 0.0001
865 HYPOGLYCAEMIA 5 0.0001
866 DYSPHONIA 6 0.0001
867 BONE PAIN 6 0.0001
868 SURGERY 6 0.0001
869 SKIN FISSURES 2 0.0001
870 NASAL CONGESTION 6 0.0001
871 ASCITES 3 0.0001
872 DISABILITY 2 0.0001
873 BLOOD PRESSURE ABNORMAL 2 0.0001
874 DRY EYE 5 0.0001
875 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
876 PRODUCT ADMINISTRATION ERROR 2 0.0001
877 DYSKINESIA 4 0.0001
878 BLINDNESS 4 0.0001
879 FEMUR FRACTURE 3 0.0001
880 SWOLLEN TONGUE 3 0.0001
881 DEPRESSED MOOD 5 0.0001
882 PALPITATIONS 11 0.0001
883 HYPERHIDROSIS 12 0.0001
884 NIGHT SWEATS 3 0.0001
885 RHINORRHOEA 6 0.0001
886 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
887 RASH PRURITIC 5 0.0001
888 IMPAIRED HEALING 3 0.0001
889 DIZZINESS 45 0.0001
890 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
891 TYPE 2 DIABETES MELLITUS 3 0.0001
892 GAIT DISTURBANCE 17 0.0001
893 FALL 29 0.0001
894 DRY MOUTH 7 0.0001
895 RASH MACULAR 3 0.0001
896 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
897 SWELLING 8 0.0001
898 ACCIDENT 1 0.0001
899 CEREBROVASCULAR ACCIDENT 14 0.0001
900 PANIC ATTACK 3 0.0001
901 ACCIDENTAL OVERDOSE 3 0.0001
902 BALANCE DISORDER 7 0.0001
903 EYE SWELLING 3 0.0001
904 HYPOAESTHESIA 12 0.0001
905 DYSARTHRIA 3 0.0001
906 ADVERSE DRUG REACTION 7 0.0001
907 THERAPY CESSATION 4 0.0001
908 ERYTHEMA 16 0.0001
909 SKIN ULCER 2 0.0001
910 ADVERSE REACTION 1 0.0001
911 OVERDOSE 16 0.0001
912 THROAT TIGHTNESS 2 0.0001
913 ACUTE HEPATIC FAILURE 1 0.0001
914 URTICARIA 12 0.0001
915 NECK PAIN 4 0.0001
916 WOUND 2 0.0001
917 INSOMNIA 19 0.0001
918 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
919 PAIN 43 0.0001
920 SYNCOPE 7 0.0001
921 PARAESTHESIA 11 0.0001
922 HERPES ZOSTER 4 0.0001
923 MOBILITY DECREASED 5 0.0001
924 EYE IRRITATION 4 0.0001
925 AGITATION 5 0.0001
926 CATARACT 4 0.0001
927 WEIGHT INCREASED 15 0.0001
928 HAEMORRHAGE 7 0.0001
929 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
930 ILL-DEFINED DISORDER 4 0.0001
931 MEMORY IMPAIRMENT 9 0.0001
932 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
933 COGNITIVE DISORDER 3 0.0001
934 MIGRAINE 6 0.0001
935 MOOD SWINGS 2 0.0001
936 HYPOTHYROIDISM 2 0.0001
937 METABOLIC ACIDOSIS 2 0.0001
938 PRURITUS 24 0.0001
939 CARDIAC FAILURE CONGESTIVE 5 0.0001
940 HIP FRACTURE 2 0.0001
941 LACTIC ACIDOSIS 2 0.0001
942 NO ADVERSE EVENT 11 0.0001
943 DRUG DOSE OMISSION 10 0.0001
944 MUSCLE SPASMS 11 0.0001
945 NASOPHARYNGITIS 11 0.0001
946 TOXICITY TO VARIOUS AGENTS 10 0.0001
947 HYPERSENSITIVITY 11 0.0001
948 GASTRIC DISORDER 2 0.0001
949 SPEECH DISORDER 3 0.0001
950 HEART RATE DECREASED 2 0.0001
951 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
952 CRYING 2 0.0001
953 DYSURIA 2 0.0001
954 FEELING ABNORMAL 13 0.0001
955 BRONCHITIS 4 0.0001
956 OROPHARYNGEAL PAIN 5 0.0001
957 CARDIAC DISORDER 5 0.0001
958 ASTHMA 6 0.0001
959 PAIN IN EXTREMITY 15 0.0001
960 DISCOMFORT 3 0.0000
961 LUNG NEOPLASM MALIGNANT 2 0.0000
962 MUSCULOSKELETAL STIFFNESS 4 0.0000
963 NEPHROLITHIASIS 2 0.0000
964 BURNING SENSATION 3 0.0000
965 OCULAR HYPERAEMIA 2 0.0000
966 FLUSHING 4 0.0000
967 ANXIETY 11 0.0000
968 BLOOD GLUCOSE INCREASED 7 0.0000
969 DISTURBANCE IN ATTENTION 2 0.0000
970 ARTHROPATHY 2 0.0000
971 IRRITABILITY 2 0.0000
972 JOINT SWELLING 4 0.0000
973 THERAPEUTIC RESPONSE DECREASED 2 0.0000
974 ADVERSE EVENT 3 0.0000
975 EXPOSURE DURING PREGNANCY 2 0.0000
976 HEART RATE INCREASED 3 0.0000
977 MYOCARDIAL INFARCTION 5 0.0000
978 RHEUMATOID ARTHRITIS 3 0.0000
979 DIABETES MELLITUS 2 0.0000
980 ABNORMAL BEHAVIOUR 1 0.0000
981 INJECTION SITE BRUISING 2 0.0000
982 INFLUENZA LIKE ILLNESS 2 0.0000
983 EMOTIONAL DISTRESS 2 0.0000
984 AMNESIA 1 0.0000
985 PRODUCT QUALITY ISSUE 2 0.0000
986 ACNE 1 0.0000
987 DEPRESSION 3 0.0000
988 INJECTION SITE PAIN 2 0.0000